1,631 top medical experts on Non-Hodgkin Lymphoma across 63 countries and 40 U.S. states, including 1,580 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Non-Hodgkin Lymphoma: Any of a group of malignant tumors of lymphoid tissue that differ from hodgkin disease, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant reed-sternberg cells, a characteristic of Hodgkin's disease.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lymphoma (3,090) and Narrower Categories: B-Cell Lymphoma (4,024), Follicular Lymphoma (3,399), Immunoblastic Large-Cell Lymphoma (285), Mantle-Cell Lymphoma (2,849), T-Cell Lymphoma (2,298).
  4. Clinical Trials ClinicalTrials.gov : at least 1,714 including 152 Active, 779 Completed, 297 Recruiting


  

        

                    


    Computing Expert Listing ...

);